Loading term…
A causality assessment conclusion indicating a reasonable possibility that the drug caused or contributed to the adverse event, triggering reporting obligations.
A patient develops a known drug-class effect with appropriate timing and positive dechallenge. The assessment concludes the event is 'related' to the suspect drug.
21 CFR 312.32, ICH E2A
Requiring certainty for a 'related' assessment. Regulatory definitions typically use 'reasonable possibility' as the threshold.
What threshold do you use for a 'related' assessment? How do you document the rationale?